B1617

B1617 News

Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19, says top US health official
Health

Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19, says top US health official

"The data is coming in, and it looks very encouraging that the US-approved vaccines do have effectiveness against this variant called B1617," Dr Francis Collins, Director of the National Institute of Science said